CompanyCPIXNasdaqNashville,, TN

Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals develops small-molecule therapeutics for multiple indications.

SEC EDGAR ClinicalTrials.gov cumberlandpharma.com

8-K/ASep 11Latest SEC filing, period to Apr 21

Aug 4Latest story

August 2026

Cumberland shares DMD and cancer trial data, closes Apotex sale in Q2 update

Aug 4Quarterly updateCumberland Pharmaceuticals Inc

July 2026

Cumberland closes $100 million asset sale to Apotex, keeps rare disease pipeline

Jul 1Regulatory decisionCumberland Pharmaceuticals Inc